MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

MENLO PARK, Calif., April 16, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other ...

Nine posters demonstrate deep insights provided by company's Multiple Sclerosis Disease Activity Test and enhanced MRI analytics and protocols Octave Bioscience, Inc., a leading precision care company ...

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States Collaboration ...

The Only Clinically Validated Multiple Sclerosis Multi-Analyte Test Proven to Deliver Clinically Meaningful Insights Is Now Available In All 50 States MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® ...

Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...

Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today the Octave Multiple ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today the Octave Multiple ...

MENLO PARK, Calif. - Octave Bioscience announced Monday a strategic collaboration with Quest Diagnostics (NYSE:DGX) to make its Multiple Sclerosis Disease Activity (MSDA) Test available through ...